Director/PDMR Shareholding

RNS Number : 3967S

Hikma Pharmaceuticals Plc

20 December 2016

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities

The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the transfer of Ordinary Shares in Darhold Limited (which owns 25.00% of the Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC ("Hikma")) from Mazen Darwazah to The TWMR Trust, a trust for the benefit of Mazen Darwazah and his family. This announcement is made in accordance with article 19.3 of MAR.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Mazen Darwazah
2	Reason for the notification
a)	Position/status	Executive Vice Chairman / PDMR
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC ('Hikma')
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Transfer of 5,449,716 Ordinary Shares of Darhold Limited (who holds 25.00% of the issues share capital of Hikma) to The TWMR Trust, a trust for the benefit of Mazen Darwazah and members of his immediate family.
c)	Price(s) and volume(s)	Price(s): £0.00 Volume(s): 0
d)	Aggregated information	Aggregated volume: 0 Price: £0.00
e)	Date of the transaction	20 December 2016
f)	Place of the transaction	Jersey

Peter Speirs, Company Secretary, Responsible for releasing this announcement

20 December 2016

 

END

 

 

DSHBUBDDXDDBGLG